DNTH Competitors & Alternatives
Compare Dianthus Therapeutics Inc. with similar stocks in the same industry
Biotechnology
DNTH
Main Stock$87.37
Tradestie Score
57
Market Cap
$1.55B
Revenue Growth
-0.6%
Analyst Upside
+46.1%
Top Competitors
219 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
KRYS
Krystal Biotech, Inc. Common Stock
|
$343.43
|
$5.20B | 46.4 | 58 | Compare |
|
PCVX
Vaxcyte, Inc. Common Stock
|
$52.11
|
$4.94B | - | 61 | Compare |
|
PTCT
PTC Therapeutics, Inc.
|
$80.96
|
$4.93B | - | 55 | Compare |
|
ARWR
Arrowhead Research Corporation
|
$82.00
|
$4.84B | - | 67 | Compare |
|
ACLX
Arcellx, Inc. Common Stock
|
$115.07
|
$4.55B | - | 57 | Compare |
|
PTGX
Protagonist Therapeutics, Inc
|
$115.03
|
$3.98B | - | 63 | Compare |
|
CRNX
Crinetics Pharmaceuticals, Inc.
|
$35.38
|
$3.92B | - | 61 | Compare |
|
KYMR
Kymera Therapeutics, Inc. Common Stock
|
$99.45
|
$3.91B | - | 65 | Compare |
|
ZLAB
Zai Lab Limited American Depositary Shares
|
$18.48
|
$3.83B | - | 53 | Compare |
|
AAPG
Ascentage Pharma Group International American Depository Shares
|
$17.13
|
$3.68B | - | 57 | Compare |
More DNTH Analysis
Data updated: Jun 23, 2026 | Industry: Biotechnology (SIC 2834)
219 stocks in this industry